This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Scott E. Millman and Cancer Research
Introduction
Scott E. Millman is an inventor associated with Memorial Sloan Kettering Cancer Center in New York, NY. His patent work concerns potential approaches to treating cancers with mutations in the p53 gene.
Latest Patents
Millman is named on 1 patent: “Methods of Treating P53 Mutant Cancers Using OGDH Inhibitors.” The patent describes the use of OGDH inhibitors as a potential treatment approach for p53-mutant cancers.
Career Highlights
Millman’s listed invention connects cancer research with the investigation of targeted treatment strategies. His work is associated with Memorial Sloan Kettering Cancer Center.
Collaborations
Among Millman’s listed coworkers are Scott Lowe and Lydia Finley.
Conclusion
Scott E. Millman’s patent reflects research into OGDH inhibitors as a potential strategy for treating p53-mutant cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
